BMRN
Biomarin Pharmaceutical Inc
63.40$
-1.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +49.7% | +7.9% | +15.1% | -4.4% | +5.9% | +24.7% | +2.7% | +6.2% | +7.3% | +2.2% | +8.7% | |
| – | -23.6% | +30.5% | +55.2% | -6.8% | -5.5% | +20.6% | -2.9% | +21.0% | +7.4% | +9.3% | +22.3% | |
| – | -54.6% | +2.8% | +46.5% | -17.4% | -11.4% | +48.4% | -9.5% | +23.4% | +4.2% | +24.9% | +39.1% | |
| – | -37.3% | +33.3% | +76.8% | -22.3% | -30.5% | +41.3% | -4.8% | +27.4% | -16.9% | +6.0% | +37.2% | |
| – | +14.2% | +30.5% | +21.4% | +31.1% | +10.1% | +18.8% | -16.7% | +23.5% | +37.4% | +4.2% | +37.5% | |
| – | +36.2% | +30.7% | +34.0% | +11.6% | +28.1% | +2.7% | +11.2% | +15.1% | +23.8% | +11.3% | +5.4% | |
| – | +34.5% | +13.4% | +12.3% | +5.8% | +6.6% | +2.1% | +0.3% | +7.6% | – | – | – | |
| – | +263.2% | +0.0% | +0.0% | +0.0% | +0.0% | -0.4% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +336.8% | -19.0% | -6.5% | -5.0% | -7.2% | -8.6% | -6.9% | -12.9% | -13.0% | -13.4% | -16.2% | |
| – | +38.0% | -5.4% | +45.1% | -20.0% | +7.4% | +11.1% | -0.5% | +2.3% | +6.7% | -29.6% | +13.2% | |
| – | +89.0% | -1.4% | +85.9% | -35.9% | +78.2% | -47.2% | +9.6% | +9.1% | +99.9% | -48.4% | +25.0% | |
| – | +3.0% | -96.6% | +1,505.8% | – | – | -96.8% | -11.0% | -0.9% | +4,744.9% | -95.4% | -62.4% | |
| – | +66.5% | -51.2% | -12.9% | +24.6% | +16.1% | -20.6% | +0.8% | +19.8% | +36.4% | -25.4% | +32.9% | |
| – | +0.7% | -0.2% | +23.1% | +2.1% | -41.4% | +121.1% | +0.4% | +0.4% | -45.2% | +0.3% | +0.3% | |
| – | +57.1% | +15.2% | +1.5% | +5.7% | +5.2% | +31.5% | +4.0% | +7.8% | +7.6% | +14.3% | +7.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.3% | +3.9% | +4.9% | +1.6% | +1.0% | +7.1% | -4.6% | +3.3% | +1.4% | +2.7% | +0.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.